Haemonetics HAE
NYSE HAE
$108.58 +0.17 (+0.16%)
At close: Aug 20, 2026 · 10:17 AM UTC

Haemonetics (HAE) Gross Profit Growth (5y) (2014 - 2026)

Haemonetics (HAE) Gross Profit Growth (5y) (2014 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 199.70 Bn 194.09 Bn 7.27 Bn
2 Stryker 129.93 Bn 126.46 Bn 4.50 Bn
3 Medtronic 120.49 Bn 111.27 Bn 6.41 Bn
4 Boston Scientific 74.60 Bn 74.06 Bn 3.85 Bn
5 Edwards Lifesciences 52.68 Bn 48.42 Bn 1.35 Bn
6 Dexcom 34.78 Bn 32.84 Bn 830.00 Mn
7 GE HealthCare Technologies 33.83 Bn 31.72 Bn 2.18 Bn
8 Koninklijke Philips 26.44 Bn 23.12 Bn 4.55 Bn
9 Steris 23.18 Bn 22.69 Bn 684.20 Mn
10 Haemonetics 4.93 Bn 4.70 Bn 202.80 Mn

Historic Data

Download Data
DateValue
Jun 27, 2026 13.41%
Mar 28, 2026 19.36%
Dec 27, 2025 10.97%
Sep 27, 2025 12.99%
Jun 28, 2025 16.38%
Mar 29, 2025 11.20%
Dec 28, 2024 8.61%
Sep 28, 2024 8.10%
Jun 29, 2024 8.58%
Mar 30, 2024 9.60%
Dec 30, 2023 9.85%
Sep 30, 2023 8.79%
Jul 1, 2023 14.98%
Apr 1, 2023 8.40%
Dec 31, 2022 7.36%
Oct 1, 2022 8.59%
Jul 2, 2022 9.19%
Apr 2, 2022 10.67%
Jan 1, 2022 6.51%
Oct 2, 2021 3.29%